Targeted Microglia Replacement Shows Promise Against Fatal Neurodegenerative Conditions
STANFORD MEDICINE RESEARCH LABORATORIES, AUG 6 – The transplant replaced over half of brain microglia in mice, extending lifespan up to 250 days and reducing symptoms of Sandhoff disease, researchers reported.
4 Articles
4 Articles
Therapeutic genetic restoration through allogeneic brain microglia replacement
Migration of transplanted allogeneic myeloid cells into the brain following systemic hematopoietic stem and progenitor cells transplantation (HCT) holds great promise as a therapeutic modality to correct genetic deficiencies in the brain such as lysosomal storage diseases.1–3 However, the toxic myeloablation required for allogeneic HCT can cause serious, life-threatening side effects limiting its applicability. Moreover, transplanted allogeneic …
Microglia Replacement Strategy Mitigates Rare Neurodegenerative Disease in Mice
Genetic neurodegenerative disorders like Tay-Sachs and Sandhoff disease currently have no effective treatments. A possible strategy is replacing affected cells with healthy ones in order to slow the neurodegenerative process. But this approach is not without challenges, including poor engraftment in the brain and a graft-versus-host response. Now scientists from Stanford University School of Medicine, University Hospital Hamburg-Eppendorf, and …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium